首页> 外文期刊>中国癌症研究(英文版) >Pathologic features and clinical outcome of central neurocytoma:analysis of 15 cases
【24h】

Pathologic features and clinical outcome of central neurocytoma:analysis of 15 cases

机译:中枢神经细胞瘤的病理特征及临床预后:附15例分析

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To get better recognition of central neurocytoma and diminish misdiagnosis.Methods:A retrospective review identified 15 cases of central neurocytoma.All cases of central neurocytoma were analyzed for their clinical symptoms,pathologic changes,immunohistochemical staining,prognosis and differential diagnosis.Clinical follow up was performed.Results:There were 8 males and 7 females aged 10-64 years (median 32.93 years).The most common presenting symptoms were those related to increased intracranial pressure (ICP),including headache (100%),papilledema (93%) and vomiting (80%).All tumors were located in the ventricular system.The tumors were composed of uniform cells with round nuclei and a fine chromatin pattern,and in some areas,small cells with perinuclear halo could be seen.In particular,the anuclear areas may have a fine fibrillary matrix (neuropil).Nuclear atypia and vascular proliferation appeared in two cases,respectively.Focal necrosis could be seen in one case.Immunohistochemical findings included expression of synaptophysin (15/15),neuron specific enolase (12/15) and glial fibrillary acidic protein (GFAP) (3/15).MIB-1 proliferation index ranged from 0.8-12.5%,and was more than 2% in 3 of 15 cases assessed.Follow-up information of 11 patients was available.Conclusions:Central neurocytoma has a favorable prognosis in general,but in some cases,the clinical course could be aggressive.Increase of GFAP positivity,proliferation index and vascular proliferation might suggest a more malignant process.
机译:目的:更好地认识中枢神经细胞瘤,减少误诊。方法:回顾性分析15例中枢神经细胞瘤,分析中枢神经细胞瘤的临床症状,病理变化,免疫组化染色,预后和鉴别诊断。结果:男8例,女7例,年龄10-64岁(中位32.93岁)。最常见的症状是与颅内压升高相关的症状,包括头痛(100%),上皮水肿(93)。 %)和呕吐(80%)。所有肿瘤均位于心室系统中。肿瘤由具有圆形核和染色质精细图案的均匀细胞组成,在某些区域可看到带有核周晕的小细胞。 ,核区可能有细纤维状基质(神经纤维瘤)。分别有2例出现核异型和血管增生。1例可见局部坏死。的化学结果包括突触素(15/15),神经元特异性烯醇化酶(12/15)和神经胶质纤维酸性蛋白(GFAP)(3/15)的表达。MIB-1的增殖指数在0.8-12.5%之间,并且大于评估15例患者中有3例的2%。有11例患者的随访信息。结论:中枢神经细胞瘤的总体预后良好,但在某些情况下,其临床过程可能较积极。GFAP阳性,增殖指数和血管增生可能提示其恶性程度更高。

著录项

  • 来源
    《中国癌症研究(英文版)》 |2012年第4期|284-290|共7页
  • 作者单位

    Institute of Neuroscience, Department of Pathology, Chongqing Medical University, Chongqing 400016, China;

    Institute of Neuroscience, Department of Pathology, Chongqing Medical University, Chongqing 400016, China;

    Institute of Neuroscience, Department of Pathology, Chongqing Medical University, Chongqing 400016, China;

    Institute of Neuroscience, Department of Pathology, Chongqing Medical University, Chongqing 400016, China;

    Institute of Neuroscience, Department of Pathology, Chongqing Medical University, Chongqing 400016, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号